Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Lifecare AS ( (DE:LFC0) ).
Lifecare ASA announced the expiration of the exercise period for its warrants, resulting in the exercise of over 3.2 million warrants at a price of NOK 5.31681 per share. This development is expected to lead to a share capital increase, with new shares being registered and delivered by late June 2025, further solidifying Lifecare’s financial positioning and potentially impacting its market presence positively.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for the sensing and monitoring of various body analytes. The company is particularly concentrated on bringing the next generation of Continuous Glucose Monitoring (CGM) systems to market, utilizing osmotic pressure as a sensing principle. Lifecare’s sensor technology is versatile, suitable for detecting and monitoring a wide range of analytes and molecules in both humans and pets.
Average Trading Volume: 41,074
Current Market Cap: NOK104.9M
Learn more about LFC0 stock on TipRanks’ Stock Analysis page.